Protagonist Therapeutics, Inc.
S&P 600
$148.18
+2.08%
Delayed · cached 15 min
Frequently asked questions
What sector does Protagonist Therapeutics, Inc. belong to?
Protagonist Therapeutics, Inc. operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of PTGX?
As of the latest available quote, PTGX traded at $148.18. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of PTGX?
Protagonist Therapeutics, Inc. has a price-to-earnings (P/E) ratio of about 142.48. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of PTGX?
The market capitalisation of Protagonist Therapeutics, Inc. is approximately $9.41B.
Is Protagonist Therapeutics, Inc. profitable?
For its latest reported financial year, Protagonist Therapeutics, Inc. recorded a negative net profit margin of about -282.83% (a net loss for the latest period).
Does PTGX pay a dividend?
Protagonist Therapeutics, Inc. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of PTGX?
Protagonist Therapeutics, Inc. has a return on equity (ROE) of about -15.47%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of PTGX?
Over the past 52 weeks, PTGX has traded between a low of $57.90 and a high of $160.81.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.